Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Inv. Zdp 29 Regulatory News (EJFZ)

Share Price Information for Ejf Inv. Zdp 29 (EJFZ)

Share Price is delayed by 15 minutes
Get Live Data
109.50    0.00 (0.00%)
Bid:
108.00
Ask:
111.00
Spread: 3.00 (2.778%)
Market Cap: -
EJFZ Live PriceLast checked at - London Stock Exchange

Intraday Ejf Inv. Zdp 29 Share Chart

Tender Offer

1 Sep 2025 07:00

RNS Number : 2794X
EJF Investments Ltd
01 September 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

 

 

01 September 2025

 

 

EJF Investments Limited (the "Company" or "EJFI")

 

EJFI Announces Tender Offer of 5% of its Ordinary Shares

The Board of EJFI, which provides investors exposure to primarily a diversified portfolio of debt issued by smaller U.S. banks and insurance companies, and participation in certain management fee income streams of EJF Capital LLC, is pleased to announce its intention to conduct the Company's first tender offer for up to 5% of Ordinary Shares in issue at a 5% discount to the Company's NAV per share (adjusted for the costs of the tender offer). The Company expects to publish a formal tender document to Ordinary Shareholders during the middle of September, which will contain full details of the tender offer, including the tender price, which is expected to be calculated by reference to the NAV per share at 31 August 2025.

On 27 November 2024, the Company announced the introduction of a periodic tender offer mechanism (referred to as the "Liquidity Option") whereby Ordinary Shareholders would be offered the opportunity (at the Board's discretion) to tender some or all of their respective holdings of ordinary shares, subject to this not exceeding an aggregate maximum of 5% of the Ordinary Shares in issue in a 12-month period. The Liquidity Option was approved by shareholders on 17 December 2024.

The Liquidity Option was introduced in recognition of the ongoing discount to NAV at which the Company's Ordinary Shares have traded. Whilst the Company's long-term objective is to increase its scale, it would like to provide an opportunity for Ordinary Shareholders to receive a return of capital for their Ordinary Shares at a premium to the Company's current prevailing share price whilst also providing an element of NAV per Ordinary Share accretion to all Ordinary Shareholders. Although the Company has seen a reduction over the year in the discount at which its Ordinary Shares trade, reducing from 27.3% at the start of the financial year to the current level of 25.0%, the Board considers it in the best interests of shareholders to implement the Liquidity Option and provide Ordinary Shareholders with the opportunity to realise a proportion of their investment at a significantly tighter discount.

John Kingston III, the Company's Chair, stated: "Although the Manager has taken constructive steps to narrow the discount meaningfully over the past 12 months and the share price has increased 27.5% over that period, the Board is determined to have the Company's shares trade closer to net asset value. The Board therefore believes that a 5% tender at a 5% discount, consistent with the authority granted by the shareholders, is the next best step to continue reducing the Company's trading discount." Mr. Kingston also noted that the Company has provided a Total Return (inclusive of dividends) of 97.79% from its inception in 2017 to 31 July 2025.

None of the Ordinary Shares held by the members of the Board will be tendered under this offer. The Manager has also informed the Board that none of the principals of the Manager or EJF Capital Limited (an affiliate of the Manager) intend to tender Ordinary Shares under this offer. The Manager and its affiliates currently hold approximately 26% of the Company's Ordinary Shares.

 

ENQUIRIES

For the Investment Manager

EJF Investments Manager LLC

Mungo Hargreaves / Jay Ghatalia

MHargreaves@ejfcap.com / jghatalia@ejfcap.com

+44 20 3752 6775 / +44 203 752 6776

 

For the Company Secretary and Administrator

Apex Financial Services (Alternative Funds) Limited 

ejficosec@apexgroup.com 

+44 204 549 0721 

 

For the Broker

Panmure Liberum Limited

Darren Vickers / Ashwin Kohli

 +44 203 100 2222

 

Barclays Bank PLC

Dion Di Miceli/Stuart Muress/James Atkinson 

BarclaysInvestmentCompanies@barclays.com

+44 207 623 2323

 

About EJF Investments Limited

EJFI's objective is to provide shareholders with attractive risk adjusted returns through regular dividends and capital growth over the long term. EJFI generates exposure primarily to a diversified portfolio of loans issued by financial institutions and related or similar assets in the U.S., U.K. and Europe.

 

EJFI currently invests primarily in CDO Equity Tranches structured by an affiliate of EJF Capital LLC, providing levered exposure to a highly diversified portfolio of securities issued by U.S. financial institutions (banks and insurance companies), these being Risk Retention Investments.

 

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

 

LEI: 549300XZYEQCLA1ZAT25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENUKOORVWUWUAR
Date   Source Headline
30th Dec 20204:33 pmRNSShareholder Letter - COVID-19 Relief Bill
21st Dec 20204:05 pmRNSCorporate Update
21st Dec 20207:00 amRNSNet Asset Value
18th Dec 20209:43 amRNSSimplification of Group Structure
16th Dec 20207:00 amRNSRecent Investment Announcement
9th Dec 20204:59 pmRNSPDMR Dealing
25th Nov 20207:00 amRNSRecent Investment Announcement
20th Nov 20207:00 amRNSNet Asset Value
26th Oct 20207:00 amRNSDividend Declaration
21st Oct 20207:00 amRNSNet Asset Value
14th Oct 202011:12 amRNSPDMR Dealings
2nd Oct 20209:53 amRNSPDMR Dealing
1st Oct 20203:06 pmRNSPDMR Dealing
25th Sep 202011:00 amRNSPDMR Dealing
21st Sep 20207:00 amRNSNet Asset Value
14th Sep 20203:38 pmRNSPDMR Dealings
9th Sep 20202:56 pmRNSAnnouncement of Interim Results to 30 June 2020
21st Aug 20207:00 amRNSNet Asset Value(s)
10th Aug 20202:55 pmRNSPDMR Dealing
6th Aug 20207:00 amRNSRecent Investment Announcement
23rd Jul 20205:17 pmRNSDividend Declaration
21st Jul 20207:00 amRNSNet Asset Value
16th Jul 20207:07 amRNSRecent Investment Announcement
3rd Jul 20202:13 pmRNSPDMR Dealings
2nd Jul 20202:51 pmRNSResults of AGM
1st Jul 20206:04 pmRNSTotal Voting Rights
24th Jun 20203:18 pmRNSPDMR Dealings
23rd Jun 202011:59 amRNSNet Asset Value - Replacement
23rd Jun 20207:00 amRNSNet Asset Value
17th Jun 20204:34 pmRNSResults of Placing
16th Jun 202012:23 pmRNSResult of EGM and ZDP Placing Update
12th Jun 20207:00 amRNSPlacing Under Placing Programme
29th May 20204:30 pmRNSNotice of Annual General Meeting
27th May 20203:25 pmRNSNotice of Extraordinary General Meeting
22nd May 20205:35 pmRNSIssue of equity and repurchase into treasury
22nd May 20207:00 amRNSNet Asset Value
14th May 20203:24 pmRNSPotential Capital Raise
30th Apr 20203:22 pmRNSPublication of Supplementary Prospectus
27th Apr 20207:00 amRNSAnnouncement of Final Results to 31 December 2019
24th Apr 20207:00 amRNSNet Asset Value(s)
24th Apr 20207:00 amRNSDividend Declaration
1st Apr 20205:04 pmRNSTotal Voting Rights
20th Mar 20207:00 amRNSNet Asset Value(s)
20th Mar 20207:00 amRNSCorporate Update
18th Mar 20204:09 pmRNSHolding(s) in Company
17th Mar 202011:27 amRNSHolding(s) in Company
13th Mar 20204:33 pmRNSTransactions in Own Shares
12th Mar 20205:43 pmRNSTransactions in Own Shares
11th Mar 20205:19 pmRNSTransactions in Own Shares
10th Mar 20205:24 pmRNSTransactions in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.